FDA panel backs easier access to peptides

NPR | By Will Stone

Published July 24, 2026 at 6:43 AM EDT

Advisers to the Food and Drug Administration are backing popular peptide therapies. They voted to allow specialized pharmacies to make them despite agency scientists' recommendations against it.

Will Stone

Support nonprofit, fact-based public service journalism

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

NPR News

Oil surges to $100 per barrel. And, Trump imposes a new round of tariffs

Brittney Melton

Oil surged to $100 per barrel after Iran-backed Houthi rebels attacked two Saudi tankers in the Red Sea. And, President Trump overnight replaced expiring tariffs with a slew of new ones.
NPR News

Trump threatens Iran escalation as tit-for-tat airstrikes continue

Jane Arraf

The U.S. continued airstrikes in Iran while Tehran launched retaliatory attacks on U.S. targets in the Gulf as the region braced itself after President Trump said he was close to deciding whether to launch "a massive attack".
U.S.-Iran strikes escalate as the ongoing war rattles global energy markets

Hadeel Al-Shalchi, Michel Martin

New U.S. strikes on Iran and continued Iranian attacks on U.S. bases in the Gulf and Jordan are sending ripples through global energy markets.
NPR News

How the Houthis blockade of the Red Sea could affect the global economy

A Martínez

NPR's A Martínez asks former U.S. deputy national security adviser Jon Finer what the blockade of the Red Sea by Houthi rebels means for the global economy.
NPR News

US allies hit with new tariffs object to Trump's forced labor claims

NPR Staff

Australia and the European Union were among U.S. trade partners who condemned the tariffs.